Prestige Consumer Healthcare, Inc. (PBH)

45.65 -0.27 (-0.59%) USD  |  NYSE  |  Sep 24, 16:00
45.64 0.00 (0.00%) Pre-Market: 19:59
More

Prestige Consumer Healthcare Gross Profit (Annual) : 574.64M for March 31, 2026

Gross Profit (Annual) Chart

View Gross Profit (Annual) for PBH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Annual) Chart
Start Trial

Historical Gross Profit (Annual) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2026 574.64M
March 31, 2025 613.17M
March 31, 2024 601.90M
March 31, 2023 600.22M
March 31, 2022 595.78M
March 31, 2021 523.53M
March 31, 2020 536.66M
March 31, 2019 528.73M
March 31, 2018 551.78M
March 31, 2017 477.94M
March 31, 2016 444.94M
March 31, 2015 390.68M
March 31, 2014 327.16M
Date Value
March 31, 2013 333.98M
March 31, 2012 218.45M
March 31, 2011 168.30M
March 31, 2010 146.88M
March 31, 2009 152.05M
March 31, 2008 157.49M
March 31, 2007 155.10M
March 31, 2006 146.46M
March 31, 2005 140.26M
March 31, 2004 141.01M
March 31, 2003 43.69M
March 31, 2002 23.51M
March 31, 2001 5.275M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (Annual) Range, Past 5 Years

View Gross Profit (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Annual) Benchmarks

View Gross Profit (Annual) Benchmarks
Start Trial
Supernus Pharmaceuticals, Inc. 552.83M
Structure Therapeutics, Inc. -3.899M
ANI Pharmaceuticals, Inc. 450.64M
Corcept Therapeutics, Inc. 748.43M
Veru, Inc. -0.1521M